| 中國醫藥大學 |
2009-10 |
A Novel Strategy for Designing Dual-target Inhibitors of KU86 and XRCC4
|
陳建宇(Chien-Yu Chen); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 黃泓縉(Hung-Jin Huang); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大靝(Da-Tian Bau)*; 蔡銘修(Ming-Hsui Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Drug Design for AMP-Activated Protein Kinase Agonists in Silico
|
陳建宇(Chien-Yu Chen); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Could Traditional Chinese Medicine Used for Curing Erectile Dysfunction
|
陳建宇(Chien-Yu Chen);包大靝(Da-Tian Bau);蔡銘修(Ming-Hsui Tsai);徐媛曼(Yuan-Man Hsu);侯庭鏞(Tin-Yun Ho);黃泓縉(Hung-Jin Huang);(Yea-Huey Chang);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Ligand-Based Dual Target Drug Design for H1N1: Swine Flu- A Preliminary First Study
|
陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 包大靝(Da-Tian Bau); (Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Drug design for Influenza A virus subtype H1N1
|
陳建宇(Chien-Yu Chen);包大靝(Da-Tian Bau);(Yea-Huey Chang);徐媛曼(Yuan-Man Hsu);侯庭鏞(Tin-Yun Ho);黃泓縉(Hung-Jin Huang);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)*;(Yu-An Chang) |
| 中國醫藥大學 |
2009-10 |
Ligand-based design for heat shock protein 90 inhibitors
|
黃泓縉(Hung-Jin Huang); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Drug Design for XRCC4 in Silico
|
黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai); 鍾景光(Jing-Gung Chung); 蔡長海(Chang-Hai Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); (Yea-Huey Chang); 包大靝(Da-Tian Bau)*; 蔡銘修(Ming-Hsui Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Dual-targeted Drug Design of HER2 and HSP90 by CoMFA Model and Pharmacophore Analysis
|
黃泓縉(Hung-Jin Huang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Reducing without Side Effects? A Novel Strategy for Designing the PPAR Agonists
|
(Yea-Huey Chang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); 黃泓縉(Hung-Jin Huang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
What is the Key Point for Designing HER2 Inhibitors
|
黃泓縉(Hung-Jin Huang); 包大靝(Da-Tian Bau); 蔡銘修(Ming-Hsui Tsai); 徐媛曼(Yuan-Man Hsu); 侯庭鏞(Tin-Yun Ho); 陳建宇(Chien-Yu Chen); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Ligand-based design for heat shock protein 90 inhibitors
|
陳建宇(Chien-yu CHEN);(Yea-huey CHANG);包大靝(Da-Tian Bau);黃泓縉(Hung-jin HUANG);蔡輔仁(Fuu-Jen Tsai)*;蔡長海(Chang-Hai Tsai)*;陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-10 |
Discovery the inhibitors of H5N1, H5N2, and H5N7 by pharmacophore analysis
|
陳建宇(Chien-yu CHEN); 黃泓縉(Hung-Jin Huang); (Yea-Huey Chang); 蔡輔仁(Fuu-Jen Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-09-04 |
Application of Nano particles for cancer therapy
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-09-04 |
Application of Nano particles for cancer therapy
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-09 |
Structure-based Drug Design of HSP 90 Inhibitors by Chen's Rules and Equation
|
陳語謙(Chen, Calvin Yu-Chian)*; (Guan-Wen Chen); (Winston Yu-Chen Chen) |
| 中國醫藥大學 |
2009-08 |
Discovery of potent inhibitors for phosphodiesterase 5 by virtual screening and pharmacophore analysis
|
陳建宇(Chien-yu CHEN); (Yea-huey CHANG); 包大靝(Da-Tian Bau); 黃泓縉(Hung-jin HUANG); 蔡輔仁(Fuu-Jen Tsai)*; 蔡長海(Chang-Hai Tsai)*; 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-07-31 |
以電腦高通量篩選具潛力中草藥物平台
|
陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-06-22 |
[Invited talk and section Chair] A novel method for evaluating protein-ligand interaction
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-06-22 |
[Invited talk and section Chair] A novel method for evaluating protein-ligand interaction
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-06 |
Discover the Novel Selective COX-2 Inhibitors by Chen's Weighted Equation
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-03-19 |
Discovery the potent inhibitors of H5N1 by pharmacophore comparison analysis
|
(Chien-Yu Chen); (Hong-Jin Huang); (Jia-Qi Lu); (Jun-Chang Wu); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-03-19 |
Designing the Novel Anti-inflammation inhibitors for mPGES-1 by Pharmacoinformatics and Chemoinformatics Approach
|
(Jia-Chi Lu); (Chien-Yu Chen; ); (Hung-Jin Huang); (Jiun-Chang Wu; ); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-03-16 |
Discovery of novel selective COX-2 inhibitors: from virtual screening to pharmacophore analysis
|
陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
Discovery of novel selective COX-2 inhibitors: from virtual screening to pharmacophore analysis
|
陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
Structure-based Drug Design and Virtual Screening of Novel Heat Shock Protein 90 Inhibitors
|
陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
Structure-based Drug Design and Virtual Screening of Novel Heat Shock Protein 90 Inhibitors
|
陳語謙(Chen, Calvin Yu-Chian); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
The novel dual-targeted inhibitors of HER2 and HSP90 investigation by 3D-QSAR and pharmacophore analysis
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
The novel dual-targeted inhibitors of HER2 and HSP90 investigation by 3D-QSAR and pharmacophore analysis
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
Development a novo inhibitor of diarrhea from ginger components by virtual screening technique
|
(Chien-Yu Chen); (Hong-Jin Huang); (Jia-Qi Lu); (Jun-Chang Wu); 侯庭鏞(Tin-Yun Ho); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-03-16 |
Investigation of the Interaction between HER2 and Ligands for Potent Drug Design
|
黃泓縉(Hung-Jin Huang); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
Virtual Screening from the Maybridge Database and Molecular Docking Approach on Discovery of H5N1 Inhibitors
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
Virtual Screening from the Maybridge Database and Molecular Docking Approach on Discovery of H5N1 Inhibitors
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-03-16 |
Discovery the potent inhibitors for phosphodiesterase 5 by multiple linear regression QSAR model prediction
|
(Chien-Yu Chen); (Hong-Jin Huang; ); (Jia-Qi Lu); (Jun-Chang Wu; ); 陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-03 |
Magnolol encapsulated by different acyl chain length of liposomes on inhibiting proliferation of smooth muscle cells
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-03 |
Calvin Weighted Equation: A Novel Method to Evaluate the HSP90-Ligands Interaction
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-03 |
Pharmacoinformatics approach for mPGES-1 in anti-inflammation by 3D-QSAR pharmacophore mapping
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-02-28 |
INSIGHT INTO THE HSP90 AND HER2 DUAL SUPPRESSED MECHANISM – FROM DOCKING, PHARMACOPHORE, AND 3D-QSAR ANALYSES
|
陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-01-12 |
[invited speech]Calvin weighted rules-A novel concept for evaluating the multiple target drug interaction with HER2, HSP90, C-MET, and AMPK
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-01-12 |
[invited speech]Calvin weighted rules-A novel concept for evaluating the multiple target drug interaction with HER2, HSP90, C-MET, and AMPK
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2009-01 |
Chemoinformatics and pharmacoinformatics approach for exploring the GABA-A agonist from Chinese herb suanzaoren
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-01 |
Insights into the Selective Inhibitors of COX-2: Evaluation and Designing by Calvin Weighted Rules and Equation
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2009-01 |
De novo design of novel selective COX-2 inhibitors: from virtual screening to pharmacophore analysis
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2008.08 |
Antiplatelet Effect and Selective Binding to Cyclooxygenase by Molecular Docking Analysis of 3-Alkylaminopropoxy-9,10-anthraquinone Derivatives
|
(Kim-Hong GAN); (Chi-Huang TENG)*; (Hsien-Cheng LIN); (Kun-Tze CHEN); 陳語謙(Chen, Calvin Yu-Chian); 許美鳳(Hsu, Mei-Feng); (Jih-Pyang WANG); (Che-Ming TENG); (Chun-Nan LIN) |
| 中國醫藥大學 |
2008-12 |
A Novel Methodology for Exploring 3D-QSAR Pharmacophore Mapping of Azaphenanthrenone derivatives for mPGES-1 inhibition
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2008-11 |
Discovery of Novel Inhibitors for c-Met by Virtual Screening and Pharmacophore Analysis
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2008-11 |
Insights into the Suanzaoren Mechanism - from Constructingthe 3D Structure of GABA-A Receptor to its Binding Interaction Analysis
|
陳語謙(Chen, Calvin Yu-Chian)* |
| 中國醫藥大學 |
2008-10-03 |
[invited speech]Application of Calvin Weighted Equation: New Insights into the Evaluation and Designing the PPAR αδ inhibitors
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2008-10-03 |
[invited speech]Application of Calvin Weighted Equation: New Insights into the Evaluation and Designing the PPAR αδ inhibitors
|
陳語謙(Chen, Calvin Yu-Chian)*; 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2008-09-15 |
Exploring 3D-QSAR Pharmacophore Mapping of Azaphenanthrenone derivatives for mPGES-1 inhibition Using HypoGen Technique
|
陳語謙(Chen, Calvin Yu-Chian); (Winston Yu-Chen Chen); 陳語謙(Chen, Calvin Yu-Chian) |
| 中國醫藥大學 |
2008-09-15 |
Exploring 3D-QSAR Pharmacophore Mapping of Azaphenanthrenone derivatives for mPGES-1 inhibition Using HypoGen Technique
|
陳語謙(Chen, Calvin Yu-Chian); (Winston Yu-Chen Chen); 陳語謙(Chen, Calvin Yu-Chian) |
